Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

What Is The Present And Forecasted Size Of The Mammalian Cell Fermentation Technology Market?

The market for mammalian cell fermentation technology has experienced significant growth in recent years. It’s projected to expand from $51.29 billion in 2024 to $57.37 billion in 2025, reflecting a compound annual growth rate (CAGR) of 11.9%. The growth during the historical period is largely due to an increase in demand for biologics and biosimilars, a more focused approach towards personalized medicine, an increase in biopharmaceutical production, and a heightened need for scalable and efficient cell culture techniques.

The market for mammalian cell fermentation technology is anticipated to experience swift expansion in the upcoming years, escalating to a staggering $87.07 billion by 2029 with a compound annual growth rate (CAGR) of 11.0%. This market growth during the prediction period can be accredited to escalating instances of chronic disease, increased funding from global corporations, a growing occurrence of chronic illnesses, the advancing adoption of innovative bioprocessing methods, increased research and development investment in innovative recombinant proteins, and the escalating demand for cancer treatment options. Predicted trends during this period encompass advancements in cell culture technology, innovation in bioreactor design, the development of next-generation bioprocessing technologies, the integration of multi-omics methods, and the advent of technology-driven automation.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16473&type=smp

Which Market Dynamics Are Playing A Critical Role In The Growth Of The Mammalian Cell Fermentation Technology Market?

The mammalian cell fermentation technology market is projected to see significant growth due to an increased demand for biologics. Derived from living organisms or their components, biologics are medical products frequently used in the treatment of diseases such as cancer, autoimmune disorders, and infectious diseases. With advancements in biotechnology leading to the development of more effective treatments for common chronic illnesses like cancer and autoimmune disorders, in addition to regulatory approvals and a rise in investment in research and development, the demand for biologics continues to increase. Mammalian cell fermentation technology is a leading method for producing complex biologics, thus meeting the ever-growing need for personalized and targeted therapies. This technology, with its scalability, versatility, and ability to produce high-quality proteins, inspires innovation within the biopharmaceutical sector. For example, as reported by the National Library of Medicine, a medical library based in the U.S., the Food and Drug Administration (FDA) approved 55 new drugs in 2023, which included 29 new chemical entities (NCEs) and 25 new biological entities (NBEs). This was a 50% increase in approvals compared to 37 approvals in 2022. Therefore, the rising demand for biologics is fueling the expansion of the bacterial cell fermentation technology market.

What Are The Key Segment Trends Observed In The Mammalian Cell Fermentation Technology Market?

The mammalian cell fermentation technologymarket covered in this report is segmented –

1) By Type: Chinese Hamster Ovary Cell Fermentation; Human Embryonic Kidney Cell Fermentation; Baby Hamster Kidney Cell Fermentation; Murine Myeloma Cell Fermentation; Other Types

2) By Application: Monoclonal Antibodies; Recombinant Proteins; Vaccines; Hormones; Enzymes; Other Applications

3) By End-Use: Biopharmaceutical Companies; Contract Research Organizations And Contract Development and Manufacturing Organizations; Academic And Research Institutes

Which Long-Term Trends Will Play A Crucial Role In The Mammalian Cell Fermentation Technology Market?

Leading businesses in the mammalian cell fermentation technology market are focusing their efforts on innovating new technologies like mammalian cell culture to consolidate their market standing. Mammalian cell culture serves as a vital mechanism in numerous sectors such as biomanufacturing, research, and regenerative medicine, facilitating the creation of therapeutic proteins, vaccines, and functional cells or tissue analogues. For instance, Syntegon, a biotech firm based in Germany, introduced its latest Modular Bioprocessing Platform (MBP) during Achema 2024 in June, which is engineered to address fundamental production challenges in biopharmaceuticals. This cutting-edge platform provides a flexible, fully integrated, and automated solution apt for different applications, encompassing microbial and mammalian cell cultures, proteins, peptides, oligonucleotides, plasmid DNA, and recombinant vaccines. The MBP’s modular structure facilitates shorter delivery times and lowers costs while preserving high functionality and quality, abiding by the “made in Germany” norm. Its readymade cleanroom design positions all the auxiliary technology outside the cleanroom, improving efficiency and making maintenance simple.

Who Are The Leading Companies Driving The Mammalian Cell Fermentation Technology Market?

Major companies operating in the mammalian cell fermentation technology market are AbbVie Inc., Thermo Fisher Scientific Inc, AstraZeneca PLC, Roche Holdings Inc., Merck KGaA, AGC Group, Lonza Group Ltd., Boehringer Ingelheim GmbH, Catalent Inc., Sartorius AG, Samsung Biologics Co. Ltd., WuXi Biologics, Biocon Limited, Eppendorf AG, KBI Biopharma Inc., Fujifilm Diosynth Biotechnologies, Avid Bioservices Inc., BiOZEEN, Nordmark Pharma GmbH, Scorpius BioManufacturing Inc

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/mammalian-cell-fermentation-technology-global-market-report

Which Region Is Forecasted To Lead The Mammalian Cell Fermentation Technology Market In The Coming Years?

North America was the largest region in the mammalian cell fermentation technology market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the mammalian cell fermentation technology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=16473&type=smp

Browse Through More Reports Similar to the Global Mammalian Cell Fermentation Technology Market 2025, By The Business Research Company

Cell Based Assays Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cell-based-assays-global-market-report

Stem Cell Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/stem-cell-global-market-report

Cellular Telephone Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cellular-telephone-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model